Previous Close | 0.2500 |
Open | N/A |
Bid | 0.0000 |
Ask | 0.7500 |
Strike | 17.50 |
Expire Date | 2024-08-16 |
Day's Range | 0.2500 - 0.2500 |
Contract Range | N/A |
Volume | |
Open Interest | 7 |
Investors need to pay close attention to Enfusion (ENFN) stock based on the movements in the options market lately.
NEW YORK & LONDON & HONG KONG, May 29, 2024--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced that Enfusion’s Chief Executive Officer, Oleg Movchan, and Chief Financial Officer, Brad Herring, and Chief Operating Officer, Neal Pawar, will participate at the following investor events:
On May 20, 2024, Bronwen Bastone, Chief People Officer of Enfusion Inc (NYSE:ENFN), executed a sale of 34,059 shares of the company, as reported in a recent SEC Filing.